ReviewThe Lancet regional health. Western Pacific2022
Toward a third term of Health Japan 21 - implications from the rise in non-communicable disease burden and highly preventable risk factors.
Review in The Lancet regional health. Western Pacific, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
36 citing papers in PubMed, 51 citations in OpenAlex.
- Cost-effectiveness analysis of early antihypertensive treatment for hypertension detected at health screening.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Ambulatory blood pressure is higher in smokers than in nonsmokers: a systematic review and meta-analysis of observational studies.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Differences in ambulatory blood pressure and heart rate between smoking and abstinence periods among current smokers: A systematic review and meta-analysis.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Impact of cocoa flavanols on blood pressure and vascular function: an updated systematic review and meta-analysis of randomized controlled trials.The journal of nutrition, health & aging · 2026Article
- Japan's global health engagement in the Western Pacific: diagnosing structural inertia and a framework for human security diplomacy.The Lancet regional health. Western Pacific · 2026Review
- Effect Modification by Exercise Habit on the Association Between Participation in Community Gathering Places and Cognitive Disability.Journal of the American Geriatrics Society · 2026Article
- Why healthy life expectancy estimates diverge: insights from survey-based, administrative, and model-based metrics across Japanese prefectures, 2001-2019: a comparative ecological study.Population health metrics · 2026Article
- Are changes in the urinary sodium-to-potassium ratio associated with changes in blood pressure in a healthy population with low urinary sodium-to-potassium ratios? Eight-year follow-up results from the KOBE Study.Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Forecasting Stomach Cancer Burden from High Sodium Intake in Japan, 2022-2050: Scenario Analysis of Demographic Disparities.Nutrients · 2026Article
- Influence of multidimensional determinants on physical activity behavior: a perspective from health promotion and behavior change theories.Frontiers in public health · 2026Article
- Burden and temporal trends of non-communicable diseases from 1990 to 2021 and prediction to 2035 in the group of twenty countries: a systematic analysis of the Global Burden of Disease Study 2021.Frontiers in microbiology · 2026Article
- The Japanese Society of Hypertension Guidelines for the management of elevated blood pressure and hypertension 2025 (JSH2025).Hypertension research : official journal of the Japanese Society of Hypertension · 2026Article
- Health information sources and behaviour changes in a community population: a longitudinal study.Environmental health and preventive medicine · 2026Article
- An alternative dietary variety score reflects nutrient adequacy across different life stages in Japanese women.Frontiers in nutrition · 2026Article
- A simulation study of the impact of population-wide lifestyle modifications on life expectancy in the Chinese population.Nature communications · 2025Article
- The JSH Morning Hypertension Eradication Program Project.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
- Article
- Three decades of population health changes in Japan, 1990-2021: a subnational analysis for the Global Burden of Disease Study 2021.The Lancet. Public health · 2025Article
- Overcoming barriers to primary care research in Japan: a call to action.The Lancet regional health. Western Pacific · 2025Article
- Temporal trends in adherence to lifestyle recommendations of patients with hypertension in Korea, 2007-2021.Hypertension research : official journal of the Japanese Society of Hypertension · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In 2000, the Japanese government launched the National Health Promotion Movement known as Health Japan 21 (HJ21), a 13-year national health promotion policy (2000-2012) aimed at preventing and controlling non-communicable diseases (NCDs) and their underlying risk factors. After the revision in 2013 (2013-2023), the target NCDs and risk factors are being reviewed and a new strategy for the third term of HJ21 is going to be discussed. Using the latest findings from the Global Burden of Disease Study 2019, this paper highlights NCDs that continue to increase health losses and preventable metabolic and behavioural risk factors. These NCDs and risk factors are associated with an increased risk of serious illness and death from the novel coronavirus disease (COVID-19). The third term of HJ21 will be formulated during the continuing threat of acute health crises like the current COVID-19 pandemic and thus offers an important opportunity to renew public health efforts to halt the growing burden of NCDs in Japan. This article may serve as one of the roadmaps for the formulation of the third term of HJ21.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.